FURESTEM-AD Inj.

BIOLOGICAL2 trials

Sponsors

Kang Stem Biotech Co., Ltd.

Conditions

Atopic Dermatitis

Phase 1

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD)

CompletedNCT01927705

Kang Stem Biotech Co., Ltd.Atopic Dermatitis

Start: 2013-09-30End: 2015-05-31Updated: 2016-10-06

Phase 3

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)

CompletedNCT03269773

Kang Stem Biotech Co., Ltd.Atopic Dermatitis

Start: 2018-04-25End: 2019-06-20Updated: 2019-09-12